Cargando…

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines

In spite of remarkable preclinical efficacy, DNA vaccination has demonstrated low immunogenicity in humans. While efforts have focused on increasing cross-presentation of DNA-encoded antigens, efforts to increase DNA vaccine immunogenicity by targeting direct presentation have remained mostly unexpl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colluru, Viswa Teja, McNeel, Douglas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356528/ https://www.ncbi.nlm.nih.gov/pubmed/27661128 http://dx.doi.org/10.18632/oncotarget.12178

Ejemplares similares

B lymphocyte mediated antigen presentation of plasmid DNA
por: Colluru, Viswa Teja, et al.
Publicado: (2013)

Role of B cells as antigen presenting cells
por: Rastogi, Ichwaku, et al.
Publicado: (2022)

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
por: Johnson, Laura E., et al.
Publicado: (2017)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination
por: Becker, Jordan T, et al.
Publicado: (2013)

The Role of Multiscale Protein Dynamics in Antigen Presentation and T Lymphocyte Recognition
por: Eccleston, R. Charlotte, et al.
Publicado: (2017)

Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer
por: McNeel, Douglas G., et al.
Publicado: (2018)

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
por: Accolla, Roberto S., et al.
Publicado: (2019)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
por: Jeon, Donghwan, et al.
Publicado: (2022)

Mechanisms of Direct and Indirect Presentation of Self-Antigens in the Thymus
por: Březina, Jiří, et al.
Publicado: (2022)

B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses
por: Rossetti, Renata Ariza Marques, et al.
Publicado: (2018)

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles
por: Sullivan, Jeremy A., et al.
Publicado: (2020)

Vaccines as treatments for prostate cancer
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Cytotoxic T Lymphocyte Antigen 4 Haploinsufficiency Presenting As Refractory Celiac-Like Disease: Case Report
por: Collen, Lauren V., et al.
Publicado: (2022)

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
por: McCarthy, Patrick M., et al.
Publicado: (2023)

An Overview of B-1 Cells as Antigen-Presenting Cells
por: Popi, Ana F., et al.
Publicado: (2016)

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials
por: Olson, Brian M., et al.
Publicado: (2013)

A Novel Antigen-Sampling Cell in the Teleost Gill Epithelium With the Potential for Direct Antigen Presentation in Mucosal Tissue
por: Kato, Goshi, et al.
Publicado: (2018)

CD40L-adjuvanted DNA vaccine carrying EBV-LMP2 antigen enhances anti-tumor effect in NPC transplantation tumor animal
por: Lei, Lei, et al.
Publicado: (2018)

Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
por: Fehres, Cynthia M., et al.
Publicado: (2014)

Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine Development
por: Fehres, Cynthia M., et al.
Publicado: (2013)

Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs
por: Hughes, Catherine E., et al.
Publicado: (2016)

The Antigen Presenting Potential of CD21(low) B Cells
por: Reincke, Marlene E., et al.
Publicado: (2020)

Exploring the known chemical space of the plant kingdom: insights into taxonomic patterns, knowledge gaps, and bioactive regions
por: Domingo-Fernández, Daniel, et al.
Publicado: (2023)

His-tag ELISA for the detection of humoral tumor-specific immunity
por: Goodell, Vivian, et al.
Publicado: (2008)

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
por: Scarpelli, Matthew, et al.
Publicado: (2019)

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
por: Zahm, Christopher D., et al.
Publicado: (2021)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
por: Murata, Kenji, et al.
Publicado: (2020)

The Other Function: Class II-Restricted Antigen Presentation by B Cells
por: Adler, Lital N., et al.
Publicado: (2017)

Antigen Presentation in the Lung
por: Kawasaki, Takumi, et al.
Publicado: (2022)

B lymphocytes secrete antigen-presenting vesicles
Publicado: (1996)

Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine
por: OKAZAKI, Seiji, et al.
Publicado: (2017)

A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
por: Wang, Longlong, et al.
Publicado: (2018)

T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination
por: Hemmi, Masahisa, et al.
Publicado: (2017)

Mycobacterium leprae Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for Leprosy
por: Bezerra-Santos, Márcio, et al.
Publicado: (2018)

Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum
por: Tang, Chun-lian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vstf55ahjk175p3n70ul6uau29